Cargando…
Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
Chondrosarcomas are primary cancers of cartilaginous tissue with highly contrasting prognoses. These tumors are defined by recurrent mutations in the IDH genes and other genetic alterations including inactivation of CDKN2A and COL2A1; however, these have no clinical value. Here we use multi-omics mo...
Autores principales: | Nicolle, Rémy, Ayadi, Mira, Gomez-Brouchet, Anne, Armenoult, Lucile, Banneau, Guillaume, Elarouci, Nabila, Tallegas, Matthias, Decouvelaere, Anne-Valérie, Aubert, Sébastien, Rédini, Françoise, Marie, Béatrice, Labit-Bouvier, Corinne, Reina, Nicolas, Karanian, Marie, le Nail, Louis-Romée, Anract, Philippe, Gouin, François, Larousserie, Frédérique, de Reyniès, Aurélien, de Pinieux, Gonzague |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789144/ https://www.ncbi.nlm.nih.gov/pubmed/31604924 http://dx.doi.org/10.1038/s41467-019-12525-7 |
Ejemplares similares
-
The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target
por: Iseulys, Richert, et al.
Publicado: (2019) -
Intraosseous Hibernoma: A Rare Entity in Orthopedics With Peculiar Radiological Features
por: Samargandi, Ramy, et al.
Publicado: (2023) -
Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
por: Bertin, Hélios, et al.
Publicado: (2023) -
The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets
por: David, E., et al.
Publicado: (2011) -
Whole-Transcriptome Profiling on Small FFPE Samples: Which Sequencing Kit Should Be Used?
por: Hilmi, Marc, et al.
Publicado: (2022)